Species profile · FDA CVM July 2026 extract
Fish adverse-event record
According to FDA CVM openFDA filings as of July 2026 extract, 168 adverse-event reports span 5 fish breeds.
- #14 of 55
- by report volume (all species)
- 168
- adverse-event reports
- 5
- breeds in this species
- 82.7%
- death-coded share
The record at a glance
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Fish ranks #14 of 55 by total reports (168) and #2 of 41 by death-coded share (82.7%). National dual: Dog is #1 of 55 species by total adverse-event reports (806,331) at death-coded share 4.3% (rank 38 of 41); separately, Quail is #1 highest death-coded share at 84.6% (report rank #32).
- 806,331
- Dog reports (#1)
- 84.6%
- Quail death share (#1)
- #14
- This species, reports of 55
- #2
- This species, death share of 41
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Fish has 168 reports now versus 168 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- −0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Fish changesFish breeds by report volume
Exclusive partition of the 5 fish breed rows with adverse-event aggregates. Parts sum to this species' breed total.
Where Fish sits among species by death-coded share
COUNT-derived placement among 20 species with at least 50 FDA CVM reports. Death-coded share is exposure in the file, not a proven species risk rate.
Fish death-coded share vs every floor-qualified species
Death-coded share of FDA CVM reports · species with ≥50 reports (July 2026 extract)
83% 95th percentile Higher share than 95% of 20 indexed species
Each bar is a band; taller bars hold more indexed species. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source FDA Center for Veterinary Medicine · openFDA animal-and-veterinary adverse-event reports · July 2026 extract
Top Reactions
Most Referenced Drugs
Outcome Breakdown
Reports by Year
Fish Adverse Event Insights
The FDA Center for Veterinary Medicine database holds 168 adverse event reports for Fish, distributed across 5 distinct breeds currently tracked in the system. Of those reports, 139 involved a death outcome, producing a 82.7% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.
The most frequently reported clinical signs for Fish are Death (91 reports), IGA Animal mortality greater than expected (41 reports), Fish body deformity (32 reports), Moribund (24 reports), with Death leading the reaction traffic at 91 submissions. On the product side, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is the single most-referenced drug with 88 reports, followed by Florfenicol (34), Florfenicol Premix Pwd Aquacul (19), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage (7). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Fish reporting patterns against other companion animals in the dataset.
Of the 179 Fish reports with a coded outcome, Died accounts for the largest share at 60.9%. Annual submission volume spans 2 to 19 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 5 tracked fish breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.
Fish Breeds (5)
| # | Breed | Reports | Deaths | Death Rate | Avg Age |
|---|---|---|---|---|---|
| 1 | Atlantic Salmon (Salmo salar) | 97 | 96 | 99.0% | 0.7 yr |
| 2 | Fish (unknown) | 18 | 10 | 55.6% | 8.4 yr |
| 3 | Trout - Golden/Rainbow/Redband/Steelhead | 10 | 7 | 70.0% | 3.0 yr |
| 4 | Fish (other) | 9 | 8 | 88.9% | 8.0 yr |
| 5 | Catfish (unspecified) | 5 | 0 | 0.0% | - |
What to do with fish data
- Look up any fish breed's report volume and death-coded share in the full breed directory. Browse breeds
- Read how death-coded share differs from a mortality rate before drawing conclusions. Breed-specific risks guide
- See how species compare nationwide by report volume and death-coded share. Rankings
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Read our methodology - how this data is sourced, computed, and verified.
Related
According to the FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Event extract, every figure on this page is rendered from that public file; no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.